Table 2.
Antiretroviral Therapy Class | n = 146 (%) |
---|---|
Nucleoside reverse transcriptase inhibitor | 138 (95) |
Protease inhibitor | 89 (61) |
Nonnucleoside reverse transcriptase inhibitor | 53 (36) |
Other | 4 (3) |
Antiretroviral Therapy Class | n = 146 (%) |
---|---|
Nucleoside reverse transcriptase inhibitor | 138 (95) |
Protease inhibitor | 89 (61) |
Nonnucleoside reverse transcriptase inhibitor | 53 (36) |
Other | 4 (3) |